MoneyWorks4Me

Sanofi India - Quaterly Results

13 May 2024 Evaluate
The revenue slipped marginally during the March 2024 quarter. A decline of about Rs. 7324.00 millions was observed as compared to Rs. 7365.00 millions during the corresponding quarter last year.The Net Profit of the company registered a slight decline of -28.26% to Rs. 1366.00  millions from Rs. 1904.00 millions.A decline of 2254.00 millions was observed in the OP in the quarter ended March 2024 from 2557.00 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202312 202212 % Var
Sales 7324.00 7365.00 -0.56 7324.00 7365.00 -0.56 28511.00 27701.00 2.92
Other Income 65.00 258.00 -74.81 65.00 258.00 -74.81 653.00 715.00 -8.67
PBIDT 2254.00 2557.00 -11.85 2254.00 2557.00 -11.85 8693.00 7759.00 12.04
Interest 3.00 3.00 0.00 3.00 3.00 0.00 17.00 17.00 0.00
PBDT 1984.00 2732.00 -27.38 1984.00 2732.00 -27.38 8854.00 9062.00 -2.30
Depreciation 100.00 97.00 3.09 100.00 97.00 3.09 396.00 419.00 -5.49
PBT 1884.00 2635.00 -28.50 1884.00 2635.00 -28.50 8458.00 8643.00 -2.14
TAX 518.00 731.00 -29.14 518.00 731.00 -29.14 2426.00 2437.00 -0.45
Deferred Tax -82.00 -7.00 1071.43 -82.00 -7.00 1071.43 -7.00 -15.00 -53.33
PAT 1366.00 1904.00 -28.26 1366.00 1904.00 -28.26 6032.00 6206.00 -2.80
Equity 230.00 230.00 0.00 230.00 230.00 0.00 230.00 230.00 0.00
PBIDTM(%) 30.78 34.72 -11.36 30.78 34.72 -11.36 30.49 28.01 8.85
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..